A new capillary sampling kit for the determination of Tamoxifen in blood has been financed by Vinnova

Together with the company Adduct Analys AB, redhot diagnostics has been financed from Vinnova to develop a cost-effective, easy-to-use, non-invasive capillary sampling kit for dose monitoring of Tamoxifen. Capillary sampling would allow a layman to take the test with simple instructions and the patient would not have to go to primary care for the help of a nurse or other trained staff.

Therapeutic drug monitoring (TDM) analysis is a prerequisite for individual drug treatment. The purpose of TDM is to improve the individual benefit of treatment and reduce the number of patients at risk of insufficient clinical effect, or side effects due to excessive concentrations. Although there are major individual differences in the way drugs are metabolized in different patients, routine TDM is used for relatively few drugs in health care.

Today there are no monitoring of Tamoxifen at all. A standard dose is given to all patients and they are expected to continue this medication for a recommended period of 5 to 10 years. Many patients experience side-effects due to too high does, 20 % of the patients is getting a to low dose and about 50% of the patients self-interrupt their treatment.

There are about 500 000 women in Europe that are under treatment by Tamoxifen. By creating self-sampling options, we facilitate for the patient to take a sample, reduce load on primary health care units and reduce costs. Patients in sparsely populated regions gives an easier access to a good health care. It will become health-economical gains from more effective healthcare.

redhot diagnostics AB in brief.

redhot diagnostics is a diagnostic company with a unique business structure that takes ideas / prototypes from academic research to product to market. This is done through completed processes in a thoughtful, fast and cost-effective way. This concept gives the academic researcher a unique way to easily reach the market with its product idea

Adduct Analys AB in brief

The company shall conduct research, development and application of methods for analysis of electrophilic substances.

Vinnova in brief

 is Sweden’s government agency for innovation. Our mission is to contribute to sustainable growth by improving the conditions for innovation. We do this mainly by funding innovation projects and the research needed to develop new solutions. We also invest long term in strong research and innovation environments.